Published in CMAJ on September 01, 1997
Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin Vaccine Immunol (2006) 1.03
Immunoglobulin A (IgA) deficiency and alternative celiac disease-associated antibodies in sera submitted to a reference laboratory for endomysial IgA testing. Clin Diagn Lab Immunol (2000) 1.02
Detection of adult celiac disease with duodenal screening biopsies over a 30-year period. Can J Gastroenterol (2013) 1.01
Screening for celiac disease. CMAJ (1997) 0.77
Antibody screening for celiac disease. CMAJ (1998) 0.75
The changing face of celiac disease. Paediatr Child Health (2001) 0.75
IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease. Lancet (1983) 3.17
Coeliac disease, epilepsy, and cerebral calcifications. The Italian Working Group on Coeliac Disease and Epilepsy. Lancet (1992) 2.62
Celiac sprue. N Engl J Med (1991) 2.45
Diagnosis of coeliac disease: time for a change? Arch Dis Child (1989) 1.76
Alpha gliadin antibody levels: a serological test for coeliac disease. Br Med J (Clin Res Ed) (1983) 1.62
Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child (1991) 1.61
Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut (1994) 1.57
Selective IgA deficiency and coeliac disease. Scand J Gastroenterol (1992) 1.53
Effect of gluten-free diet on bone mineral content in growing patients with celiac disease. Am J Clin Nutr (1993) 1.37
Predictive value for coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy. BMJ (1991) 1.34
High prevalence of celiac disease in healthy adults revealed by antigliadin antibodies. Ann Allergy (1992) 1.25
Compliance of adolescents with coeliac disease with a gluten free diet. Gut (1991) 1.24
Anti-gliadin antibodies. J Pediatr Gastroenterol Nutr (1991) 1.23
Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin Exp Immunol (1994) 1.21
Can antigliadin antibody detect symptomless coeliac disease in children with short stature? Lancet (1985) 1.14
Need for follow up in coeliac disease. Arch Dis Child (1994) 1.13
IgG, IgA and IgE gliadin antibody determinations as screening test for untreated coeliac disease in children, a multicentre study. Eur J Pediatr (1989) 1.11
High prevalence of undiagnosed coeliac disease in 5280 Italian students screened by antigliadin antibodies. Acta Paediatr (1995) 1.09
IgA anti-gliadin antibodies in adult celiac disease. Clin Chem (1991) 1.05
Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease. J Pediatr Gastroenterol Nutr (1995) 1.00
Antigliadin antibodies detected by enzyme-linked immunosorbent assay as a marker of childhood celiac disease. J Pediatr (1988) 0.87
IgA antigliadin antibodies, cellobiose/mannitol sugar test, and carotenemia in the diagnosis of and screening for celiac disease. Am J Gastroenterol (1991) 0.86
Celiac disease is a lifelong disorder. Clin Invest Med (1996) 0.84
The diagnostic value of the gliadin antibody test in celiac disease in children: a prospective study. J Pediatr Gastroenterol Nutr (1993) 0.82
Serological screening for coeliac disease: methodological standards and quality control. Acta Paediatr Suppl (1996) 0.82
Prevalence and clinical significance of gliadin antibodies in healthy children and adults. Scand J Gastroenterol (1994) 0.81
Diagnosis of coeliac sprue in 1994. Gastroenterol Clin North Am (1995) 0.81
Screening tests for enteropathy in children. Am J Dis Child (1987) 0.81
Anti-gliadin antibody panel and xylose absorption test in screening for celiac disease. J Pediatr Gastroenterol Nutr (1990) 0.80
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology (2000) 2.99
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology (1998) 2.38
Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy (2007) 2.14
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease. Aliment Pharmacol Ther (2013) 2.12
An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy. Inflamm Bowel Dis (2001) 1.77
Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res (2001) 1.57
Distinct patterns of cow's milk allergy in infancy defined by prolonged, two-stage double-blind, placebo-controlled food challenges. Clin Exp Allergy (1996) 1.51
Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome. Am J Kidney Dis (2000) 1.39
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease. Aliment Pharmacol Ther (2013) 1.32
Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology (2000) 1.32
Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut (2003) 1.23
Successful videocapsule endoscopy in patients with an abdominal cardiac pacemaker. Endoscopy (2007) 1.19
Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol (2001) 1.17
Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy. Can J Physiol Pharmacol (1996) 1.16
Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Dig Dis Sci (1997) 1.14
Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment Pharmacol Ther (2009) 1.13
Dientamoeba fragilis masquerading as allergic colitis. J Pediatr Gastroenterol Nutr (1998) 1.09
Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Differ (1999) 1.08
Ocular sequelae of BB injuries to the eye and surrounding adnexa. J Am Optom Assoc (1998) 1.04
Triglyceride levels affect cognitive function in noninsulin-dependent diabetics. J Diabet Complications (1989) 0.97
Liver transplantation for hereditary tyrosinemia: the Quebec experience. Am J Hum Genet (1990) 0.97
Autoimmune enteropathy. Pediatr Dev Pathol (1999) 0.97
Tyrosine kinase and MAPK inhibition of TNF-alpha- and EGF-stimulated IEC-6 cell growth. Biochem Biophys Res Commun (1998) 0.95
Use of mental health services by persons with a mental illness in nursing facilities: initial impacts of OBRA87. J Aging Health (2000) 0.95
Susceptibility to FAS-induced apoptosis in human nontumoral enterocytes: role of costimulatory factors. J Cell Physiol (1999) 0.94
Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). Clin Exp Immunol (1998) 0.93
TNFalpha-induced IEC-6 cell apoptosis requires activation of ICE caspases whereas complete inhibition of the caspase cascade leads to necrotic cell death. Biochem Biophys Res Commun (1999) 0.92
Effects of interferon gamma on growth, apoptosis, and MHC class II expression of immature rat intestinal crypt (IEC-6) cells. J Cell Physiol (1998) 0.92
Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease. Clin Exp Immunol (2003) 0.92
Increased permeability to polyethylene glycol 4000 in rabbits with experimental colitis. Gastroenterology (1986) 0.90
Susceptibility loci reported in genome-wide association studies are associated with Crohn's disease in Canadian children. Aliment Pharmacol Ther (2010) 0.90
Interpretation of bone mineral density values in pediatric Crohn's disease. Inflamm Bowel Dis (1998) 0.90
The economic burden of congestive heart failure in a managed care population. Am J Manag Care (2000) 0.90
Inhibition by deacetylase inhibitors of IL-1-dependent induction of haptoglobin involves CCAAT/Enhancer-binding protein isoforms in intestinal epithelial cells. Biochem Biophys Res Commun (2000) 0.89
Staged repair of pentalogy of Cantrell with tetralogy of Fallot. Ann Thorac Surg (1993) 0.89
Hospitalization and total medical costs for privately insured persons with schizophrenia. Adm Policy Ment Health (2001) 0.88
A two-tier polymerase chain reaction direct sequencing method for detecting and typing human papillomaviruses in pathological specimens. Diagn Mol Pathol (1998) 0.87
Celiac disease is a lifelong disorder. Clin Invest Med (1996) 0.84
The susceptibility to Fas-induced apoptosis in normal enterocytes is regulated on the level of cIAP1 and 2. Biochem Biophys Res Commun (2002) 0.83
Amplifications of DNA primase 1 (PRIM1) in human osteosarcoma. Genes Chromosomes Cancer (1999) 0.83
Mannan-binding lectin in children with Escherichia coli O157:H7 haemmorrhagic colitis and haemolytic uraemic syndrome. Clin Exp Immunol (2003) 0.82
Relapsing pancreatitis in association with Crohn's disease. J Pediatr Gastroenterol Nutr (1983) 0.82
High-frequency jet versus conventional ventilation in infants undergoing Blalock-Taussig shunts. Ann Thorac Surg (1994) 0.82
Steroid-resistant lymphocytic enterocolitis and bronchitis responsive to 6-mercaptopurine in an adolescent. J Pediatr Gastroenterol Nutr (1997) 0.82
Modulation of endoplasmic reticulum-bound cholesterol regulatory enzymes by iron/ascorbate-mediated lipid peroxidation. Free Radic Biol Med (2000) 0.81
Inflammatory bowel disease in pediatric patients. Curr Opin Gastroenterol (1999) 0.81
Cytokine--intestinal epithelial cell interactions: implications for immune mediated bowel disorders. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi (1998) 0.80
Retrospective practice review of treatment of metastatic non-small-cell lung cancer with second-line erlotinib. Curr Oncol (2008) 0.80
Immunopathogenesis of inflammatory bowel disease: role of cytokines and immune cell-enterocyte interactions. Nestle Nutr Workshop Ser Clin Perform Programme (1999) 0.80
The effect of inflammation severity and of treatment on the production and release of TNFalpha by colonic explants in inflammatory bowel disease. Aliment Pharmacol Ther (2000) 0.79
Uptake and metabolism of structured triglyceride by Caco-2 cells: reversal of essential fatty acid deficiency. Am J Physiol (1998) 0.79
Subcapsular hepatic necrosis in orthotopic liver allografts. Hepatology (1986) 0.79
Variable expression of familial heterozygous hypobetalipoproteinemia: transient malabsorption during infancy. J Lipid Res (1994) 0.79
Endogenous lipase activity in Caco-2 cells. Biochim Biophys Acta (1998) 0.78
Autoimmunity with immunodeficiency: a logical paradox. J Pediatr Gastroenterol Nutr (1999) 0.78
Direct human papillomavirus (HPV) sequencing method yields a novel HPV in a human immunodeficiency virus-positive Quebec woman and distinguishes a new HPV clade. J Infect Dis (1998) 0.78
Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis. J Pediatr Gastroenterol Nutr (1993) 0.78
Immunolocalization, ontogeny, and regulation of microsomal triglyceride transfer protein in human fetal intestine. Am J Physiol Gastrointest Liver Physiol (2001) 0.78
Effect of inhibitors of oxygen radical and nitric oxide formation on UV radiation-induced erythema, immunosuppression and carcinogenesis. Redox Rep (1999) 0.78
JC9813-A putative novel human papillomavirus identified by PCR-DS. Biochem Biophys Res Commun (1998) 0.78
Caco-2 cells and human fetal colon: a comparative analysis of their lipid transport. Biochim Biophys Acta (1999) 0.78
What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?--Results from the lung cancer economics and outcomes research (LUCEOR) study. Lung Cancer (2013) 0.78
Nutrition as primary therapy in pediatric Crohn's disease: fact or fantasy? J Pediatr (2000) 0.77
The Peter Brojde lung cancer centre: a model of integrative practice. Curr Oncol (2012) 0.77
Endopeptidase inhibition and intestinal antigen processing in mice. Reg Immunol (1993) 0.77
Pneumatosis intestinalis and colocolic intussusception complicating Crohn's disease. J Pediatr Gastroenterol Nutr (2000) 0.77
Wheat starch intolerance in patients with celiac disease. J Am Diet Assoc (1997) 0.77
Hyperornithinemia, hyperammonemia, homocitrullinuria (HHH) syndrome: presentation as acute liver disease with coagulopathy. J Pediatr Gastroenterol Nutr (1992) 0.77
Chronic alterations in cardiac mechanics after fetal closed heart operation. Ann Thorac Surg (1994) 0.76
Dexamethasone inhibits IFNgamma-induced MHC class II expression of intestinal epithelial cells independently of the TGF-beta1 regulatory pathway. Aliment Pharmacol Ther (1999) 0.76
Effects of halothane on the immature lamb heart. Ann Thorac Surg (1995) 0.76
Mesalamine in pediatric inflammatory bowel disease: a 10-year experience. Inflamm Bowel Dis (1996) 0.76
The potential role for acupuncture in treating symptoms in patients with lung cancer: an observational longitudinal study. Curr Oncol (2013) 0.76
Thiopurine metabolite ratios for monitoring therapy in pediatric Crohn disease. J Pediatr Gastroenterol Nutr (2014) 0.76
Detection of growth-stimulating activity in the proximal small intestine during weaning in the suckling rat. Biol Neonate (1991) 0.76
Diagnostic markers of inflammatory bowel disease. Curr Opin Gastroenterol (2000) 0.75
Pressure-volume relationship of the fetal lamb heart. Ann Thorac Surg (1993) 0.75
6-Mercaptopurine in maintaining remission in Crohn's disease: An old friend becomes a new hero. Gastroenterology (2000) 0.75
Retrosternal fat pad for prevention of suppurative sternitis. Ann Thorac Surg (1998) 0.75
Endocardectomy for the surgical treatment of endocardial fibrosis of the left ventricle. Thorax (1985) 0.75
Genetic aspects of disorders in beta-lipoproteins. J Pediatr Gastroenterol Nutr (1992) 0.75
Low-resolution gamma-ray measurements of process hold-up. Appl Radiat Isot (1998) 0.75
Pathologic quiz case 2. Granulomatous lymphadenitis with rodlike bacteria suggestive of cat-scratch organisms. Arch Otolaryngol Head Neck Surg (1986) 0.75
Portoenterostomy in a case of Alagille's syndrome with extrahepatic biliary atresia. J Pediatr Surg (1991) 0.75
Pacing-induced ventricular remodeling in the chick embryonic heart. Pediatr Res (1999) 0.75
[Univentricular heart. Septation as a surgical treatment]. G Ital Cardiol (1981) 0.75
Waterston anastomosis in two-stage correction of severe tetralogy of Fallot: ten years of experience. Ann Thorac Surg (1982) 0.75
Facing reality: a team approach. J Christ Nurs (2000) 0.75
Novel immunosuppressive therapies for intestinal and hepatic diseases. Curr Opin Pediatr (1999) 0.75
Apparent insatiability: an unrecognized manifestation of food intolerance in breast-fed infants. Pediatrics (1994) 0.75
[2-dimensional-echodoppler "integrated echography": Ebstein's anomaly. Uhl's anomaly]. Boll Soc Ital Cardiol (1981) 0.75
Gastrointestinal manifestations of primary immunodeficiencies. Curr Opin Gastroenterol (2001) 0.75
Acute renal failure complicating nonfulminant hepatitis A in childhood. Nephron (1996) 0.75
Mechanisms of hypercholesterolaemia in glycogen storage disease type I: defective metabolism of low density lipoprotein in cultured skin fibroblasts. Eur J Clin Invest (1990) 0.75
Operative creation of left to right cardiac shunts: pulmonary functional sequelae. Ann Thorac Surg (1993) 0.75